Skip to main content
Equibles

VICTORY CAPITAL MANAGEMENT INC

Position in ANIP — Ani Pharmaceuticals Inc

CIK 1040188 San Antonio, TX
Back to ANIP Full portfolio

Position in ANIP

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$3,312,690
-$4,420,758 QoQ
Shares Held
40,018
-60.2% QoQ
Ownership
0.174%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#86
of 305 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ANIP Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

VICTORY CAPITAL MANAGEMENT INC holds $597,918,972 across 29 Drug Manufacturers - Specialty & Generic names. ANIP ranks #16 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 2,122,749 $152,540,743
2 NBIX
Neurocrine Biosciences Inc
 618,499 $104,241,821
3 TEVA
Teva Pharmaceutical Industries Ltd
 1,575,098 $53,364,320
4 LNTH
Lantheus Holdings, Inc.
 470,051 $52,147,457
5 ALKS
Alkermes plc.
 916,709 $48,035,551
6 VTRS
Viatris Inc
 2,683,275 $42,610,407
7 KNSA
Kiniksa Pharmaceuticals International, plc
 504,853 $32,285,348
8 COLL
Collegium Pharmaceutical, Inc
 760,252 $27,521,122

All Filings in ANIP

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,312,690 40,018
2026-03-31 $7,733,448 100,565
2025-12-31 $6,403,218 81,115
2025-09-30 $5,875,590 64,144
2025-06-30 $5,200,686 79,704
2025-03-31 $1,128,977 16,863
2024-12-31 $761,592 13,777
2024-09-30 $770,747 12,919
2024-06-30 $324,385 5,094
2024-03-31 $472,088 6,829
2022-09-30 $632,033 19,665
2022-06-30 $594,112 20,024
2022-03-31 $539,262 19,184
2021-12-31 $1,157,944 25,129
2021-09-30 $922,996 28,123
2021-06-30 $1,132,115 32,300
2021-03-31 $2,088,639 57,793
2020-03-31 $516,053 12,667